Cargando…
A model for determining cardiac mitochondrial substrate utilisation using stable (13)C-labelled metabolites
INTRODUCTION: Relative oxidation of different metabolic substrates in the heart varies both physiologically and pathologically, in order to meet metabolic demands under different circumstances. (13)C labelled substrates have become a key tool for studying substrate use—yet an accurate model is requi...
Autores principales: | Lindsay, Ross T., Demetriou, Demetris, Manetta-Jones, Dominic, West, James A., Murray, Andrew J., Griffin, Julian L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892366/ https://www.ncbi.nlm.nih.gov/pubmed/31773381 http://dx.doi.org/10.1007/s11306-019-1618-y |
Ejemplares similares
-
β-hydroxybutyrate accumulates in the rat heart during low-flow ischaemia with implications for functional recovery
por: Lindsay, Ross T, et al.
Publicado: (2021) -
Direct arterial injection of hyperpolarized (13)C‐labeled substrates into rat tumors for rapid MR detection of metabolism with minimal substrate dilution
por: Reynolds, Steven, et al.
Publicado: (2017) -
Ethyl Pyruvate Increases Post-Ischemic Levels of Mitochondrial Energy Metabolites: A (13)C-Labeled Cerebral Microdialysis Study
por: Nygaard, Kevin H., et al.
Publicado: (2020) -
Substrate utilisation of cultured skeletal muscle cells in patients with CFS
por: Tomas, Cara, et al.
Publicado: (2020) -
Mitochondrial responses to extreme environments: insights from metabolomics
por: O’Brien, Katie A, et al.
Publicado: (2015)